Sarah R Reed

Title: The Innovative Contributions of Sarah R. Reed

Introduction

Sarah R. Reed is a prominent inventor based in Santa Cruz, California. She has made significant contributions to the field of biotechnology, particularly in the development of human antibodies. With a total of two patents to her name, her work has the potential to impact various medical applications.

Latest Patents

Reed's latest patents focus on human antibodies that bind to CD22. The present disclosure provides isolated monoclonal antibodies that specifically bind to CD22 with high affinity, particularly human monoclonal antibodies. Nucleic acid molecules encoding these antibodies, expression vectors, host cells, and methods for expressing the antibodies are also included. Additionally, antibody-partner molecule conjugates, bispecific molecules, and pharmaceutical compositions comprising these antibodies are provided. This disclosure also outlines methods for detecting CD22, as well as methods for treating various cancers and inflammatory and autoimmune disorders using an anti-CD22 antibody.

Career Highlights

Throughout her career, Sarah R. Reed has worked with notable companies such as Medarex Inc. and E.R. Squibb & Sons, LLC. Her experience in these organizations has contributed to her expertise in the field of antibody development and biotechnology.

Collaborations

Reed has collaborated with several professionals in her field, including David J. King and Alison Witte. These collaborations have likely enhanced her research and development efforts.

Conclusion

Sarah R. Reed's innovative work in the development of human antibodies showcases her significant contributions to biotechnology. Her patents and collaborations reflect her commitment to advancing medical science and improving treatment options for various diseases.